Pharma White Paper

Home » Pharma White Paper

Data-Driven Personas Help Take the Edge Off Risked-Based Life Science Contracts

Few recent trends have had as profound an effect on life sciences organisations as the healthcare industry’s transition to value-based care with its focus on outcomes. No longer is it enough to deliver drugs and devices that have proven to be effective in clinical trials. Today, life sciences organisations are being asked to assume part [...]

In Vivo Models to Target Respiratory Diseases

Intuitive analysis and insights into methods of optimising in vivo efficacy studies and what developments might be coming to fruition in the future Scientists involved in biopharmaceutical and biomedical research seek to generate the highest quality data for their studies by employing an optimal combination of in vivo and ex vivo models. The 3Rs principle [...]

Patient Personas: Changing Behaviours Starts with Understanding What Drives Them

One of the key factors that separates championship coaches from those who never reach the summit is their ability to get the best out of each athlete on their teams. They work hard to get to know their players so they can understand what motivates each of them, from how they interact with the athletes [...]

Regenerative Medicine and the Benefits of Cell-Based Combinatorial Screening Technology

The purpose of regenerative medicine is to replace or regenerate diseased cells, tissues or entire organs to restore or establish normal function. This may be achieved by a variety of means, including the use of cell and gene therapy, tissue engineering or regenerative drug therapy. The allogeneic transplantation of bone marrow or umbilical cord blood [...]

The Impact of Calorimetry Based 3D Phenotype Assays

Magnus Jansson, PhD, Chief Scientific Officer, SymCel Sverige AB A necessity for drug discovery and personalised medicine Modern drug discovery is based predominantly on parameter research. Individual factors such as gene expression levels, protein levels, protein activity and localisation are measured and extrapolated into in vivo function for treatment in humans. The measurement of factors [...]

Research and Development: Industry’s Road to Success

Manufacturing flexibility has never been as important for industry as it is today. In a world of interconnected devices and smart factories, the ability of a manufacturer to innovate and adapt to its customers’ requirements is vital. For many manufacturers, the road to innovation starts with research and development (R&D). Here Andrew Keith, Engineering Director [...]

England’s Pharmacies Provide More Than Just Medicine

England’s pharmacies are at major risk of a funding epidemic. More than 11,700 pharmacies across England provide valuable services to patients and communities, particularly in rural regions. However, with proposed government cuts to subsidies looming, up to 3000 of the country’s pharmacies are at risk ofbeing closed. Adrian Pittock, Marketing Director of Valley Northern, a UK leading pharmacy and healthcare supplier, investigates what can be done to support our pharmacies and build immunity [...]

Healthcare’s Digital Revolution

Doctor Crawford W. Long conducted the first surgical operation under anaesthetic in 1841 in Jefferson, Georgia. Here Jonathan Wilkins, marketing director of obsolete parts supplier, EU Automation discusses the technologies that are revolutionising healthcare in the 21st century. In 1841, general anaesthetic had not yet been invented, so Dr Long used diethyl ether, a chemical most commonly used to start internal combustion engines, in [...]

Why Pharma Companies Should Prepare for EU General Data Protection Regulation in the New Year … Regardless of Brexit

John Culkin, Director of Information Management, Crown Records Management Pharmaceutical companies are being told to think twice before cancelling or delaying preparations for the forthcoming EU General Data Protection Regulation (GDPR), as the UK prepares to push ahead with Brexit in 2017. Businesses across the country have been studying implications of the new [...]

A Cure for Pharmaceutical Supply Chain Complexity

The pharmaceutical industry lags in the sophistication and performance of its supply chains when they are compared with best-in-class companies in other industries. This is due to the complexity that has come with new drugs, more complex production technologies and evolving regulatory requirements. In this environment, integrating and aligning the supply chain makes it more flexible, bolstering operational performance and financial [...]